Ionic Versus Nonionic Contrast Media Solvents Used with an Epirubicin-based Agent for Transarterial Chemoembolization of Hepatocellular Carcinoma
Open Access
- 31 March 2008
- journal article
- research article
- Published by Elsevier BV in Journal of Vascular and Interventional Radiology
- Vol. 19 (3), 342-350
- https://doi.org/10.1016/j.jvir.2007.10.021
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Transarterial Chemoembolization for Hepatocellular CarcinomaJournal of the American College of Surgeons, 2006
- Prognosis following transcatheter arterial embolization for 121 patients with unresectable hepatocellular carcinoma with or without a history of treatmentWorld Journal of Gastroenterology, 2006
- Liver Cancer on the RiseAnnals of Internal Medicine, 2005
- Advanced Hepatocellular Carcinoma: Treatment with High-Intensity Focused Ultrasound Ablation Combined with Transcatheter Arterial EmbolizationRadiology, 2005
- The role of transcatheter arterial embolization for patients with unresectable hepatocellular carcinoma: a nationwide, multicentre study evaluated by cancer stageAlimentary Pharmacology & Therapeutics, 2005
- Chemoembolization for hepatocellular carcinomaGastroenterology, 2004
- Hepatocellular carcinomaThe Lancet, 2003
- Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Meta-Analysis of Randomized Controlled TrialsRadiology, 2002
- Locoregional Therapies for Hepatocellular Carcinoma: A Critical Review From the Surgeon’s PerspectiveAnnals of Surgery, 2002
- Peripheral hepatic artery embolization for primary and secondary hepatic neoplasms.Radiology, 1983